To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers
Clinical trial NCT03867331 · COMPLETED
Trial details
- NCT number
- NCT03867331
- Sponsor
- VLP Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-13
- Primary completion
- 2020-05-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.